- Brand name eyeglasses, Frames, contact lenses, Sunglasses, Safety Glasses, and Quality Replacement Lenses at the most affordable prices

Shop Our Products


VIDEO: Combined procedure effective in failed trabeculectomy cases

Juan Carlos Izquierdo, MD, discusses a study he presented looking at ab interno canaloplasty combined with ECP in patients with previous failed trabeculectomy at the virtual American Society of Cataract and Refractive Surgery meeting....

>Read More

Antibiotic resistance associated with staphylococcal ocular isolates

Antibiotic resistance among commonly used topical antibiotics is significant, first author of the ARMOR study results told Healio/OSN. The ARMOR surveillance study gives us an incredible view of eye infections over 10 years in the U.S., Penny A. Asbell, MD, MBA, of the department of ophthalmology at the University of Tennessee Health Science Center in Memphis, said. The study, which looked at more than 6,000 isolates from 88 sites across 41 states, determined that more than one-third of Staphylo...

>Read More

Artificial intelligence detects COVID-19 for the first time in US

Researchers at the Icahn School of Medicine at Mount Sinai created the first algorithm of its kind in the United States to use artificial intelligence, combined with CT imaging of lungs and clinical data, to detect COVID-19, according to a press release. We have a collaboration with different hospitals in China, Zahi Fayad, PhD, director of the BioMedical Engineering and Imaging Institute at the Icahn School of Medicine at Mount Sinai, told Healio Primary Care. We integrated some of their patien...

>Read More

RPE cell transplant therapy shows signs of retinal regeneration in early results

A patient enrolled in a phase 1/2a study of OpRegen for dry age-related macular degeneration showed signs of retinal tissue regeneration, according to a press release. After retinal pigment epithelium cell transplantation with Lineage Cell Therapeutics lead product candidate in one patient of 17 so far enrolled, geographic atrophy was 25% smaller at 9 months than at baseline. In the next 6 months, the area grew approximately 50% slower than its historical rate, according to the release. The data...

>Read More

Aldeyra plans advancement of reproxalap for dry eye

Following preliminary discussion with the FDA, Aldeyra Therapeutics plans to continue advancing reproxalap for dry eye disease, according to a company press release. In the discussions, the use of reactive aldehyde species (RASP) was decided to be an objective sign for the treatment of dry eye disease, the release said. RASP, pre-cytokine pro-inflammatory mediators, present in elevated capacities in patients with dry eye disease. In a phase 2a clinical trial, the investigational RASP inhibitor r...

>Read More

VIDEO: Ophthalmologist discusses causes, remedies of quarantine myopia'

Ella Faktorovich, MD, founder of Pacific Vision Institute in San Francisco, discusses a new phenomenon in the peer-review literature called quarantine myopia in children. Faktorovich outlines the risk factors and ages of children most at risk as well as remedies that may lessen myopia progression due to being quarantined during the COVID-19 pandemic....

>Read More

AbbVie CEO to keynote virtual Octane meeting

Octanes Ophthalmology Technology Summit is now rescheduled for Aug. 6-8 and will be held virtually, according to a press release. AbbVie CEO and chairman of the board Richard A. Gonzalez is slated as keynote speaker for the event. Upon AbbVies separation from Abbott in 2013, Gonzalez had already served in a variety of senior leadership positions, including Abbott president and chief operating officer. In addition to hearing from Gonzalez, Attendees can expect to hear from executives, leaders and...

>Read More